Maxidim Injection 500 mg/vial contains Ceftazidime Pentahydrate, a third-generation cephalosporin antibiotic widely used for the treatment of moderate to severe bacterial infections. It is particularly effective against Gram-negative organisms, including Pseudomonas aeruginosa, and is commonly prescribed in hospital and clinical settings. Maxidim Injection is intended for parenteral administration and should be used under the supervision of qualified healthcare professionals.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Ceftazidime Pentahydrate equivalent to Ceftazidime 500 mg

• Dosage Form: Powder for injection

• Route of Administration: Intravenous or Intramuscular (after reconstitution)

Therapeutic Class

• Third-Generation Cephalosporin Antibiotic

Pharmacology

Ceftazidime is a bactericidal beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. This action leads to disruption of cell wall integrity and bacterial cell death. Ceftazidime is resistant to many beta-lactamases and exhibits strong activity against a wide range of Gram-negative bacteria, including Pseudomonas aeruginosa, as well as selected Gram-positive organisms. After injection, it distributes well into body tissues and fluids such as the lungs, urinary tract, skin, bones, joints, and cerebrospinal fluid in cases of inflamed meninges.

Indications

Maxidim Injection 500 mg/vial is indicated for the treatment of infections caused by susceptible organisms, including:

• Lower and upper respiratory tract infections

• Urinary tract infections

• Skin and soft tissue infections

• Bone and joint infections

• Intra-abdominal infections

• Septicemia

• Meningitis

• Infections in immunocompromised patients

It may also be used as empirical therapy in severe infections before laboratory confirmation.

Dosage and Administration

The dosage of Maxidim Injection depends on the severity and type of infection, patient age, body weight, and renal function.

• Administered intravenously or intramuscularly after appropriate reconstitution

• Dose adjustment is required in patients with renal impairment

• Duration of treatment should be determined by the physician based on clinical response

Administration should be performed by trained healthcare professionals only.

Benefits and Key Features

• Broad-spectrum antibacterial activity

• Highly effective against Gram-negative bacteria, including Pseudomonas aeruginosa

• Suitable for serious and hospital-acquired infections

• Rapid bactericidal action

• Proven safety and efficacy in clinical practice

Possible Side Effects

Some patients may experience side effects such as:

• Pain, redness, or swelling at the injection site

• Nausea or vomiting

• Diarrhea

• Skin rash or itching

• Transient changes in liver enzymes or blood parameters

Most adverse effects are mild and reversible. Hypersensitivity reactions, although rare, require immediate medical attention.

Precautions and Warnings

• Contraindicated in patients with known hypersensitivity to cephalosporins

• Use with caution in patients allergic to penicillins

• Renal function should be monitored during therapy

• Prolonged use may lead to overgrowth of non-susceptible organisms

• Use during pregnancy and breastfeeding only if clearly indicated

Storage

• Store below 30°C in a dry place

• Protect from light

• Use reconstituted solution as recommended by the manufacturer

• Keep out of reach of children

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Conclusion

Maxidim Injection 500 mg/vial (Ceftazidime Pentahydrate) is a dependable and effective antibiotic for the treatment of moderate to severe bacterial infections. Its strong activity against resistant Gram-negative pathogens and established clinical effectiveness make it a valuable option in modern antimicrobial therapy when used responsibly under medical supervision.